Literature DB >> 23903954

The effect of gonadal status on body composition and bone mineral density in transfusion-dependent thalassemia.

P Wong1, P J Fuller, M T Gillespie, V Kartsogiannis, F Milat, D K Bowden, B J Strauss.   

Abstract

UNLABELLED: Patients with transfusion-dependent thalassemia have abnormal growth, hormonal deficits, and increased bone loss. We investigated the relationship between skeletal muscle mass, fat mass, and bone mineral density in adult subjects with transfusion-dependent thalassemia based on their gonadal status. Our findings show that hypogonadism attenuates the strength of the muscle-bone relationship in males but strengthens the positive correlation of skeletal muscle mass and fat mass in female subjects.
INTRODUCTION: Transfusion-dependent thalassemia is associated with a high prevalence of fractures. Multiple hormonal complications, in particular hypogonadism, can lead to changes in body composition and bone mineral density (BMD). We investigated for the first time the relationship between skeletal muscle mass (SMM), fat mass, and BMD in adult subjects with transfusion-dependent thalassemia based on their gonadal status.
METHODS: A retrospective cohort study of 186 adults with transfusion-dependent thalassemia was analyzed. Body composition and BMD were measured using dual energy X-ray absorptiometry. The association between skeletal muscle, fat, and BMD was investigated through uni-, multi-, and stepwise regression analyses after adjusting for multicollinearity. SMM was derived using the formula, SMM = 1.19 × ALST-1.65, where ALST is equivalent to the sum of both arm and leg lean tissue mass.
RESULTS: There were 186 subjects, males (43.5 %) and females (56.5 %), with a median age of 36.5. Hypogonadism was reported in 44.4 % of males and 44.7 % of females. SMM and BMD were positively correlated and strongest in eugonadal males (0.36 ≤ R (2) ≤ 0.59), but the association was attenuated in hypogonadal males. SMM (0.27 ≤ R (2) ≤ 0.69) and total fat mass (0.26 ≤ R (2) ≤ 0.55) were positively correlated with BMD in hypogonadal females, but the correlation was less pronounced in eugonadal females. Leg lean tissue mass and arm lean tissue mass in males and females, respectively, were most highly correlated to BMD in the stepwise regression analysis.
CONCLUSION: Hypogonadism attenuates the strength of the muscle-bone relationship in males but strengthens the positive correlation of skeletal muscle mass and fat mass in female subjects. This study supports the notion that exercise is important for maintaining BMD and the need to optimize treatment of hypogonadism in patients with transfusion-dependent thalassemia.

Entities:  

Mesh:

Year:  2013        PMID: 23903954     DOI: 10.1007/s00198-013-2454-y

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  24 in total

1.  Bone mass in young women is dependent on lean body mass.

Authors:  Deborah Anne Kerr; Shona Papalia; Alan Morton; Ian Dick; Satvinder Dhaliwal; Richard L Prince
Journal:  J Clin Densitom       Date:  2007-06-18       Impact factor: 2.617

2.  Relationship between body composition and bone mass in women.

Authors:  S Khosla; E J Atkinson; B L Riggs; L J Melton
Journal:  J Bone Miner Res       Date:  1996-06       Impact factor: 6.741

Review 3.  Fat and bone.

Authors:  Ian R Reid
Journal:  Arch Biochem Biophys       Date:  2010-07-03       Impact factor: 4.013

4.  Relationship between chronic transfusion therapy and body composition in subjects with thalassemia.

Authors:  Ellen B Fung; Yan Xu; Janet L Kwiatkowski; Maria G Vogiatzi; Ellis Neufeld; Nancy Olivieri; Elliott P Vichinsky; Patricia J Giardina
Journal:  J Pediatr       Date:  2010-06-12       Impact factor: 4.406

5.  Role of serum leptin, insulin, and estrogen levels as potential mediators of the relationship between fat mass and bone mineral density in men versus women.

Authors:  T Thomas; B Burguera; L J Melton; E J Atkinson; W M O'Fallon; B L Riggs; S Khosla
Journal:  Bone       Date:  2001-08       Impact factor: 4.398

6.  Short stature and failure of pubertal development in thalassaemia major: evidence for hypothalamic neurosecretory dysfunction of growth hormone secretion and defective pituitary gonadotropin secretion.

Authors:  C Roth; A Pekrun; M Bartz; H Jarry; S Eber; M Lakomek; W Schröter
Journal:  Eur J Pediatr       Date:  1997-10       Impact factor: 3.183

7.  Amylin stimulates osteoblast proliferation and increases mineralized bone volume in adult mice.

Authors:  J Cornish; K E Callon; G J Cooper; I R Reid
Journal:  Biochem Biophys Res Commun       Date:  1995-02-06       Impact factor: 3.575

8.  Fat mass is an important determinant of whole body bone density in premenopausal women but not in men.

Authors:  I R Reid; L D Plank; M C Evans
Journal:  J Clin Endocrinol Metab       Date:  1992-09       Impact factor: 5.958

9.  Body composition and bone mass in post-menopausal women.

Authors:  J E Compston; M Bhambhani; M A Laskey; S Murphy; K T Khaw
Journal:  Clin Endocrinol (Oxf)       Date:  1992-11       Impact factor: 3.478

10.  Hypogonadism, diabetes mellitus, hypothyroidism, hypoparathyroidism: incidence and prevalence related to iron overload and chelation therapy in patients with thalassaemia major followed from 1980 to 2007 in the Ferrara Centre.

Authors:  Maria Rita Gamberini; Vincenzo De Sanctis; Giuseppe Gilli
Journal:  Pediatr Endocrinol Rev       Date:  2008-10
View more
  3 in total

Review 1.  Rheumatic Manifestations of Haemoglobinopathies.

Authors:  Michael Hughes
Journal:  Curr Rheumatol Rep       Date:  2018-08-14       Impact factor: 4.592

2.  Nutritional Status in a Sample of Patients With β-Thalassemia Major.

Authors:  Irene Lidoriki; George Stavrou; Dimitrios Schizas; Maximos Frountzas; Lampros Fotis; Alkistis Kapelouzou; Smaro Kokkota; Barbara Fyntanidou; Katerina Kotzampassi
Journal:  Cureus       Date:  2022-08-14

3.  Body Composition in Adult Patients with Thalassemia Major.

Authors:  Marianna Vlychou; Evangelos Alexiou; Paschalis Thriskos; Ioannis Fezoulidis; Katerina Vassiou
Journal:  Int J Endocrinol       Date:  2016-11-10       Impact factor: 3.257

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.